[Bisphosphonates-induced osteonecrosis of the jaw: CT-findings].
Maksimovic
O
O
Denecke
B
B
Pintoffl
J P
JP
Horger
M
M
D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D009101:Multiple Myeloma / Q000188:drug therapy; D010014:Osteolysis / Q000139:chemically induced / Q000000981:diagnostic imaging; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011471:Prostatic Neoplasms / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
D050071:Bone Density Conservation Agents; D004164:Diphosphonates